Company Information | |
Line Description | Value |
Company Name: | |
Group Affiliation: | |
Federal EIN: | |
A.M. Best Number: | |
NAIC Group Code: | |
NAIC Company Code: | |
DBA / Marketing Name: | |
HIOS Issuer ID: | |
Business in the State of: | |
Domiciliary State: | |
Address: | |
Federal Tax Exempt: | |
Marketplace: | |
Merge Markets - Ind/SmGrp: | |
Not-For-Profit: | |
MLR Reporting Year: | |
Cell Keys for Parts 1 - 6: | |
White cells accept input from the issuer | |
Grey cells require no data input – input will result in an upload failure | |
Green cells require a calculation by the issuer | |
PRA Disclosure Statement: According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0938-1164. The time required to complete this information collection is estimated to average 63 hours or 3,804 minutes per response, including the time to review instructions, search existing data resources, gather the data needed and complete and review the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: CMS, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer, Mail Stop C4-26-05, Baltimore, Maryland 21244-1850. | |
Last updated: 4/27/23 |
Part 1 Summary of Data | |||||||||||||||||||||||||||||||||||||||||||||
Line Description | SHCE | 1 Health Insurance INDIVIDUAL Total as of 12/31/22 |
2 Health Insurance INDIVIDUAL Total as of 3/31/23 |
3 Health Insurance INDIVIDUAL Dual Contracts (Included in Total as of 3/31/23) |
4 Health Insurance INDIVIDUAL Deferred PY1 (Add) |
5 Health Insurance INDIVIDUAL Deferred CY (Subtract) |
6 Health Insurance SMALL GROUP Total as of 12/31/22 |
7 Health Insurance SMALL GROUP Total as of 3/31/23 |
8 Health Insurance SMALL GROUP Dual Contracts (Included in Total as of 3/31/23) |
9 Health Insurance SMALL GROUP Deferred PY1 (Add) |
10 Health Insurance SMALL GROUP Deferred CY (Subtract) |
11 Health Insurance LARGE GROUP Total as of 12/31/22 |
12 Health Insurance LARGE GROUP Total as of 3/31/23 |
13 Health Insurance LARGE GROUP Dual Contracts (Included in Total as of 3/31/23) |
14 Health Insurance LARGE GROUP Deferred PY1 (Add) |
15 Health Insurance LARGE GROUP Deferred CY (Subtract) |
16 Mini-Med INDIVIDUAL Total as of 12/31/22 |
17 Mini-Med INDIVIDUAL Total as of 3/31/23 |
18 Mini-Med INDIVIDUAL Dual Contracts (Included in Total as of 3/31/23) |
19 Mini-Med SMALL GROUP Total as of 12/31/22 |
20 Mini-Med SMALL GROUP Total as of 3/31/23 |
21 Mini-Med SMALL GROUP Dual Contracts (Included in Total as of 3/31/23) |
22 Mini-Med LARGE GROUP Total as of 12/31/22 |
23 Mini-Med LARGE GROUP Total as of 3/31/23 |
24 Mini-Med LARGE GROUP Dual Contracts (Included in Total as of 3/31/23) |
25 Expat SMALL GROUP Total as of 12/31/22 |
26 Expat SMALL GROUP Total as of 3/31/23 |
27 Expat SMALL GROUP Dual Contracts (Included in Total as of 3/31/23) |
28 Expat SMALL GROUP Deferred PY1 (Add) |
29 Expat SMALL GROUP Deferred CY (Subtract) |
30 Expat LARGE GROUP Total as of 12/31/22 |
31 Expat LARGE GROUP Total as of 3/31/23 |
32 Expat LARGE GROUP Dual Contracts (Included in Total as of 3/31/23) |
33 Expat LARGE GROUP Deferred PY1 (Add) |
34 Expat LARGE GROUP Deferred CY (Subtract) |
35 Student Health INDIVIDUAL Total as of 12/31/22 |
36 Student Health INDIVIDUAL Total as of 3/31/23 |
37 Student Health INDIVIDUAL Dual Contracts (Included in Total as of 3/31/23) |
38 Student Health INDIVIDUAL Deferred PY1 (Add) |
39 Student Health INDIVIDUAL Deferred CY (Subtract) |
40 Government Program Plans Total as of 12/31/22 |
41 Other Health Business Total as of 12/31/22 |
42 Medicare MLR Business Total as of 12/31/22 |
43 Uninsured Plans Total as of 12/31/22 |
44 Grand Total Total as of 12/31/22 |
1. Premium | |||||||||||||||||||||||||||||||||||||||||||||
1.1 Total direct premium earned | |||||||||||||||||||||||||||||||||||||||||||||
1.2 Federal high risk pools | Pt 1, Ln 1.2 | ||||||||||||||||||||||||||||||||||||||||||||
1.3 State high risk pools | Pt 1, Ln 1.3 | ||||||||||||||||||||||||||||||||||||||||||||
1.4 Net assumed less ceded reinsurance premium earned (exclude amounts already reported in Line 1.1) | Pt 1, Ln 1.9 | ||||||||||||||||||||||||||||||||||||||||||||
1.5 Other adjustments due to MLR calculations - premium | Pt 1, Ln 1.10 | ||||||||||||||||||||||||||||||||||||||||||||
1.6 Risk revenue | Pt 1, Ln 1.11 | ||||||||||||||||||||||||||||||||||||||||||||
2. Claims | |||||||||||||||||||||||||||||||||||||||||||||
2.1 Total incurred claims (MLR Form Part 2, Line 2.17) | |||||||||||||||||||||||||||||||||||||||||||||
2.2 Prescription drugs (informational only; already included in total incurred claims above) | Pt 1, Ln 2.2 | ||||||||||||||||||||||||||||||||||||||||||||
2.3 Pharmaceutical rebates (informational only; already excluded from total incurred claims above) | Pt 1, Ln 2.3 | ||||||||||||||||||||||||||||||||||||||||||||
2.4 State stop loss, market stabilization and claim/census based assessments (informational only; already excluded from total incurred claims above) |
Pt 1, Ln 2.4 | ||||||||||||||||||||||||||||||||||||||||||||
2.5 Net assumed less ceded claims incurred (exclude amounts already reported in Line 2.1) | Pt 1, Ln 5.1 | ||||||||||||||||||||||||||||||||||||||||||||
2.6 Other adjustments due to MLR calculations – claims incurred | Pt 1, Ln 5.2 | ||||||||||||||||||||||||||||||||||||||||||||
2.7 Rebates paid | Pt 1, Ln 5.3 | ||||||||||||||||||||||||||||||||||||||||||||
2.8 Estimated rebates unpaid at the end of the previous MLR reporting year | Pt 1, Ln 5.4 | ||||||||||||||||||||||||||||||||||||||||||||
2.9 Estimated rebates unpaid at the end of the MLR reporting year | Pt 1, Ln 5.5 | ||||||||||||||||||||||||||||||||||||||||||||
2.10 Fee-for-service and co-pay revenue (net of expenses) | Pt 1, Ln 5.6 | ||||||||||||||||||||||||||||||||||||||||||||
2.11 Allowable claims recovered through fraud reduction efforts (MLR Form Part 2, Line 2.18) | Pt 1, Ln 4 | ||||||||||||||||||||||||||||||||||||||||||||
3. Federal and State Taxes and Licensing or Regulatory Fees | |||||||||||||||||||||||||||||||||||||||||||||
3.1 Federal taxes and assessments incurred by the reporting issuer during the MLR reporting year | Pt 1, Ln 1.5 | ||||||||||||||||||||||||||||||||||||||||||||
3.1a Federal income taxes deductible from premium in MLR calculations | |||||||||||||||||||||||||||||||||||||||||||||
3.1b Patient Centered Outcomes Research Institute (PCORI) Fee | |||||||||||||||||||||||||||||||||||||||||||||
3.1c Reserved | |||||||||||||||||||||||||||||||||||||||||||||
3.1d Other Federal taxes and assessments deductible from premium | |||||||||||||||||||||||||||||||||||||||||||||
3.2 State insurance, premium and other taxes incurred by the reporting issuer during the MLR reporting year (deductible from premium in MLR calculation) | Pt 1, Ln 1.6 | ||||||||||||||||||||||||||||||||||||||||||||
3.2a State income, excise, business, and other taxes | |||||||||||||||||||||||||||||||||||||||||||||
3.2b State premium taxes | |||||||||||||||||||||||||||||||||||||||||||||
3.2c Community benefit expenditures deductible from premium in MLR calculations | Pt 1, Ln 1.6a | ||||||||||||||||||||||||||||||||||||||||||||
3.3 Regulatory authority licenses and fees | Pt 1, Ln 1.7 | ||||||||||||||||||||||||||||||||||||||||||||
3.3a Federal Transitional Reinsurance Program contributions | |||||||||||||||||||||||||||||||||||||||||||||
3.3b Other Federal and State regulatory authority licenses and fees | |||||||||||||||||||||||||||||||||||||||||||||
4. Health Care Quality Improvement Expenses Incurred | |||||||||||||||||||||||||||||||||||||||||||||
4.1 Improve health outcomes | Pt 1, Ln 6.1 | ||||||||||||||||||||||||||||||||||||||||||||
4.2 Activities to prevent hospital readmission | Pt 1, Ln 6.2 | ||||||||||||||||||||||||||||||||||||||||||||
4.3 Improve patient safety and reduce medical errors | Pt 1, Ln 6.3 | ||||||||||||||||||||||||||||||||||||||||||||
4.4 Wellness and health promotion activities | Pt 1, Ln 6.4 | ||||||||||||||||||||||||||||||||||||||||||||
4.5 Health information technology expenses related to improving health care quality | Pt 1, Ln 6.5 | ||||||||||||||||||||||||||||||||||||||||||||
4.6 Total allowable quality improvement expenses | |||||||||||||||||||||||||||||||||||||||||||||
5. Non-Claims Costs | |||||||||||||||||||||||||||||||||||||||||||||
5.1 Cost containment expenses not included in quality improvement expenses in Section 4 | Pt 1, Ln 8.1 | ||||||||||||||||||||||||||||||||||||||||||||
5.2 All other claims adjustment expenses | Pt 1, Ln 8.2 | ||||||||||||||||||||||||||||||||||||||||||||
5.3 Direct sales salaries and benefits | Pt 1, Ln 10.1 | ||||||||||||||||||||||||||||||||||||||||||||
5.4 Agents and brokers fees and commissions | Pt 1, Ln 10.2 | ||||||||||||||||||||||||||||||||||||||||||||
5.5 Other taxes | |||||||||||||||||||||||||||||||||||||||||||||
5.5a Taxes and assessments (exclude amounts reported in Section 3 or Lines 5.5c or 9) | |||||||||||||||||||||||||||||||||||||||||||||
5.5b Fines and penalties of regulatory authorities (exclude amounts reported in Line 3.3) | |||||||||||||||||||||||||||||||||||||||||||||
5.5c Federal and State employment taxes and assessments | |||||||||||||||||||||||||||||||||||||||||||||
5.6 Other general and administrative expenses | |||||||||||||||||||||||||||||||||||||||||||||
5.7 Community benefit expenditures (informational only; include amounts reported in Lines 3.2c and 5.6) | Pt 1, Ln 10.4a | ||||||||||||||||||||||||||||||||||||||||||||
6. Income from fees of uninsured plans | Pt 1, Ln 12 | ||||||||||||||||||||||||||||||||||||||||||||
7. Other Indicators or information | |||||||||||||||||||||||||||||||||||||||||||||
7.1 Number of policies/certificates | Pt 1 Other, Ln 1 | ||||||||||||||||||||||||||||||||||||||||||||
7.2 Number of covered lives | Pt 1 Other, Ln 2 | ||||||||||||||||||||||||||||||||||||||||||||
7.3 Number of groups | Pt 1 Other, Ln 3 | ||||||||||||||||||||||||||||||||||||||||||||
7.4 Member months | Pt 1 Other, Ln 4 | ||||||||||||||||||||||||||||||||||||||||||||
7.5 Number of life-years | |||||||||||||||||||||||||||||||||||||||||||||
8. Net investment income and other gain / (loss) | Pt 1, Ln 13 | ||||||||||||||||||||||||||||||||||||||||||||
9. Other Federal income taxes (exclude taxes on Lines 3.1a-d) | Pt 1, Ln 14 |
Part 2 Premium and Claims | |||||||||||||||||||||||||||||||||||||||||||||
Line Description | SHCE | 1 Health Insurance INDIVIDUAL Total as of 12/31/22 |
2 Health Insurance INDIVIDUAL Total as of 3/31/23 |
3 Health Insurance INDIVIDUAL Dual Contracts (Included in Total as of 3/31/23) |
4 Health Insurance INDIVIDUAL Deferred PY1 (Add) |
5 Health Insurance INDIVIDUAL Deferred CY (Subtract) |
6 Health Insurance SMALL GROUP Total as of 12/31/22 |
7 Health Insurance SMALL GROUP Total as of 3/31/23 |
8 Health Insurance SMALL GROUP Dual Contracts (Included in Total as of 3/31/23) |
9 Health Insurance SMALL GROUP Deferred PY1 (Add) |
10 Health Insurance SMALL GROUP Deferred CY (Subtract) |
11 Health Insurance LARGE GROUP Total as of 12/31/22 |
12 Health Insurance LARGE GROUP Total as of 3/31/23 |
13 Health Insurance LARGE GROUP Dual Contracts (Included in Total as of 3/31/23) |
14 Health Insurance LARGE GROUP Deferred PY1 (Add) |
15 Health Insurance LARGE GROUP Deferred CY (Subtract) |
16 Mini-Med INDIVIDUAL Total as of 12/31/22 |
17 Mini-Med INDIVIDUAL Total as of 3/31/23 |
18 Mini-Med INDIVIDUAL Dual Contracts (Included in Total as of 3/31/23) |
19 Mini-Med SMALL GROUP Total as of 12/31/22 |
20 Mini-Med SMALL GROUP Total as of 3/31/23 |
21 Mini-Med SMALL GROUP Dual Contracts (Included in Total as of 3/31/23) |
22 Mini-Med LARGE GROUP Total as of 12/31/22 |
23 Mini-Med LARGE GROUP Total as of 3/31/23 |
24 Mini-Med LARGE GROUP Dual Contracts (Included in Total as of 3/31/23) |
25 Expat SMALL GROUP Total as of 12/31/22 |
26 Expat SMALL GROUP Total as of 3/31/23 |
27 Expat SMALL GROUP Dual Contracts (Included in Total as of 3/31/23) |
28 Expat SMALL GROUP Deferred PY1 (Add) |
29 Expat SMALL GROUP Deferred CY (Subtract) |
30 Expat LARGE GROUP Total as of 12/31/22 |
31 Expat LARGE GROUP Total as of 3/31/23 |
32 Expat LARGE GROUP Dual Contracts (Included in Total as of 3/31/23) |
33 Expat LARGE GROUP Deferred PY1 (Add) |
34 Expat LARGE GROUP Deferred CY (Subtract) |
35 Student Health INDIVIDUAL Total as of 12/31/22 |
36 Student Health INDIVIDUAL Total as of 3/31/23 |
37 Student Health INDIVIDUAL Dual Contracts (Included in Total as of 3/31/23) |
38 Student Health INDIVIDUAL Deferred PY1 (Add) |
39 Student Health INDIVIDUAL Deferred CY (Subtract) |
40 Government Program Plans Total as of 12/31/22 |
41 Other Health Business Total as of 12/31/22 |
42 Medicare MLR Business Total as of 12/31/22 |
43 Uninsured Plans Total as of 12/31/22 |
44 Grand Total Total as of 12/31/22 |
1. Premium | |||||||||||||||||||||||||||||||||||||||||||||
1.1 Direct premium written | |||||||||||||||||||||||||||||||||||||||||||||
1.2 Unearned premium prior year | Pt 2, Ln 1.2 | ||||||||||||||||||||||||||||||||||||||||||||
1.3 Unearned premium MLR Reporting year | Pt 2, Ln 1.3 | ||||||||||||||||||||||||||||||||||||||||||||
1.4 Experience rating refunds (rate credits) paid | |||||||||||||||||||||||||||||||||||||||||||||
1.4a Experience rating refunds, with all incurred dates, paid in the MLR reporting year | Pt 2, Ln 1.5 | ||||||||||||||||||||||||||||||||||||||||||||
1.4b Experience rating refunds associated with premium earned only in the reporting year and paid through 3/31 of the following year | |||||||||||||||||||||||||||||||||||||||||||||
1.5 Reserve for experience rating refunds (rate credits) MLR Reporting year | Pt 2, Ln 1.6 | ||||||||||||||||||||||||||||||||||||||||||||
1.6 Reserve for experience rating refunds (rate credits) prior year | Pt 2, Ln 1.7 | ||||||||||||||||||||||||||||||||||||||||||||
1.7 Premium balances written off | Pt 2, Ln 1.9 | ||||||||||||||||||||||||||||||||||||||||||||
1.8 Group conversion charges | Pt 2, Ln 1.10 | ||||||||||||||||||||||||||||||||||||||||||||
1.9 Federal Transitional Reinsurance Program payments | |||||||||||||||||||||||||||||||||||||||||||||
1.10 Federal Risk Adjustment Program net payments expected from HHS / (charges payable to HHS) (as indicated by HHS as of 6/30) | |||||||||||||||||||||||||||||||||||||||||||||
1.11 Reserved | |||||||||||||||||||||||||||||||||||||||||||||
1.12 Premium ceded under 100% reinsurance (informational only; already excluded from Lines 1.1-1.11) | |||||||||||||||||||||||||||||||||||||||||||||
1.13 Premium assumed under 100% reinsurance (informational only; already included in Lines 1.1-1.11) | |||||||||||||||||||||||||||||||||||||||||||||
1.14 Advance payments of the premium tax credit received from HHS (informational only; already included in Lines 1.1-1.11) | |||||||||||||||||||||||||||||||||||||||||||||
2. Claims | |||||||||||||||||||||||||||||||||||||||||||||
2.1 Claims Paid | |||||||||||||||||||||||||||||||||||||||||||||
2.1a Claims paid during the MLR reporting year regardless of incurred date | |||||||||||||||||||||||||||||||||||||||||||||
2.1b Claims incurred only during the MLR reporting year, paid through 3/31 of the following year | |||||||||||||||||||||||||||||||||||||||||||||
2.2 Direct claim liability | |||||||||||||||||||||||||||||||||||||||||||||
2.2a Liability as of 12/31 of MLR reporting year for all claims regardless of incurred date | Pt 2, Ln 2.2 | ||||||||||||||||||||||||||||||||||||||||||||
2.2b Liability for claims incurred only during the MLR reporting year, calculated as of 3/31 of the following year | |||||||||||||||||||||||||||||||||||||||||||||
2.3 Direct claim liability prior year | Pt 2, Ln 2.3 | ||||||||||||||||||||||||||||||||||||||||||||
2.4 Direct claim reserves | |||||||||||||||||||||||||||||||||||||||||||||
2.4a Reserves as of 12/31 of MLR reporting year for all claims regardless of incurred date | Pt 2, Ln 2.4 | ||||||||||||||||||||||||||||||||||||||||||||
2.4b Reserves for claims incurred only during the MLR reporting year, calculated as of 3/31 of the following year | |||||||||||||||||||||||||||||||||||||||||||||
2.5 Direct claim reserves prior year | Pt 2, Ln 2.5 | ||||||||||||||||||||||||||||||||||||||||||||
2.6 Direct contract reserves | |||||||||||||||||||||||||||||||||||||||||||||
2.6a Direct contract reserves 12/31 column | Pt 2, Ln 2.6 | ||||||||||||||||||||||||||||||||||||||||||||
2.6b Direct contract reserves 3/31, dual contract, deferred columns | |||||||||||||||||||||||||||||||||||||||||||||
2.7 Direct contract reserves prior year | Pt 2, Ln 2.7 | ||||||||||||||||||||||||||||||||||||||||||||
2.8 Experience rating refunds (rate credits) paid | |||||||||||||||||||||||||||||||||||||||||||||
2.8a Experience rating refunds, with all incurred dates, paid in the MLR reporting year | Pt 2, Ln 2.8 | ||||||||||||||||||||||||||||||||||||||||||||
2.8b Experience rating refunds associated with premium earned only in the reporting year and paid through 3/31 of the following year | |||||||||||||||||||||||||||||||||||||||||||||
2.9 Reserve for experience rating refunds (rate credits) | |||||||||||||||||||||||||||||||||||||||||||||
2.9a Reserved in MLR reporting year regardless of incurred date | Pt 2, Ln 2.9 | ||||||||||||||||||||||||||||||||||||||||||||
2.9b Reserves specific to the MLR reporting year through 3/31 of the following year | |||||||||||||||||||||||||||||||||||||||||||||
2.10 Reserve for experience rating refunds (rate credits) prior year | Pt 2, Ln 2.10 | ||||||||||||||||||||||||||||||||||||||||||||
2.11 Incurred medical incentive pool and bonuses | |||||||||||||||||||||||||||||||||||||||||||||
2.11a Paid medical incentive pools and bonuses MLR Reporting year | Pt 2, Ln 2.11a | ||||||||||||||||||||||||||||||||||||||||||||
2.11b Accrued medical incentive pools and bonuses MLR Reporting year | Pt 2, Ln 2.11b | ||||||||||||||||||||||||||||||||||||||||||||
2.11c Accrued medical incentive pools and bonuses prior year | Pt 2, Ln 2.11c | ||||||||||||||||||||||||||||||||||||||||||||
2.12 Net healthcare receivables | |||||||||||||||||||||||||||||||||||||||||||||
2.12a Healthcare receivables MLR Reporting year | Pt 2, Ln 2.12a | ||||||||||||||||||||||||||||||||||||||||||||
2.12b Healthcare receivables prior year | Pt 2, Ln 2.12b | ||||||||||||||||||||||||||||||||||||||||||||
2.13 Contingent benefit and lawsuit reserves | |||||||||||||||||||||||||||||||||||||||||||||
2.14 Group conversion charges | Pt 2, Ln 2.13 | ||||||||||||||||||||||||||||||||||||||||||||
2.15 Blended rate adjustment | Pt 2, Ln 2.14 | ||||||||||||||||||||||||||||||||||||||||||||
2.16 State Reinsurance Program payments | |||||||||||||||||||||||||||||||||||||||||||||
2.17 Total incurred claims | Pt 2, Ln 2.15 | ||||||||||||||||||||||||||||||||||||||||||||
2.18 Allowable claims recovered through fraud reduction efforts (the smaller of Lines 2.18a or 2.18b) | Pt 1, Ln 4 | ||||||||||||||||||||||||||||||||||||||||||||
2.18a Total fraud reduction expense | Pt 3, Col 7, Ln 1.11/2.11/3.11/5.11/6.11 | ||||||||||||||||||||||||||||||||||||||||||||
2.18b Total fraud recoveries that reduced paid claims in Line 2.1 | Pt 2, Ln 3 | ||||||||||||||||||||||||||||||||||||||||||||
2.19 Reconciled payments of cost-sharing reductions |
Part 3 MLR and Rebate Calculation | ||||||||||||||||||||||||||||||||||||
Line Description | 1 Health Insurance Coverage INDIVIDUAL PY2 |
2 Health Insurance Coverage INDIVIDUAL PY1 |
3 Health Insurance Coverage INDIVIDUAL CY |
4 Health Insurance Coverage INDIVIDUAL Total |
5 Health Insurance Coverage SMALL GROUP PY2 |
6 Health Insurance Coverage SMALL GROUP PY1 |
7 Health Insurance Coverage SMALL GROUP CY |
8 Health Insurance Coverage SMALL GROUP Total |
9 Health Insurance Coverage LARGE GROUP PY2 |
10 Health Insurance Coverage LARGE GROUP PY1 |
11 Health Insurance Coverage LARGE GROUP CY |
12 Health Insurance Coverage LARGE GROUP Total |
13 Mini-Med Plans INDIVIDUAL PY2 |
14 Mini-Med Plans INDIVIDUAL PY1 |
15 Mini-Med Plans INDIVIDUAL CY |
16 Mini-Med Plans INDIVIDUAL Total |
17 Mini-Med Plans SMALL GROUP PY2 |
18 Mini-Med Plans SMALL GROUP PY1 |
19 Mini-Med Plans SMALL GROUP CY |
20 Mini-Med Plans SMALL GROUP Total |
21 Mini-Med Plans LARGE GROUP PY2 |
22 Mini-Med Plans LARGE GROUP PY1 |
23 Mini-Med Plans LARGE GROUP CY |
24 Mini-Med Plans LARGE GROUP Total |
25 Expatriate Plans SMALL GROUP PY2 |
26 Expatriate Plans SMALL GROUP PY1 |
27 Expatriate Plans SMALL GROUP CY |
28 Expatriate Plans SMALL GROUP Total |
29 Expatriate Plans LARGE GROUP PY2 |
30 Expatriate Plans LARGE GROUP PY1 |
31 Expatriate Plans LARGE GROUP CY |
32 Expatriate Plans LARGE GROUP Total |
33 Student Health Plans INDIVIDUAL PY2 |
34 Student Health Plans INDIVIDUAL PY1 |
35 Student Health Plans INDIVIDUAL CY |
36 Student Health Plans INDIVIDUAL Total |
1. Medical Loss Ratio Numerator | ||||||||||||||||||||||||||||||||||||
1.1 Adjusted incurred claims as reported on MLR Form for prior year(s) | ||||||||||||||||||||||||||||||||||||
1.2 Adjusted incurred claims as of 3/31 of the year following the MLR reporting year | ||||||||||||||||||||||||||||||||||||
1.3 Improving Health Care Quality Expenses | ||||||||||||||||||||||||||||||||||||
1.4 Reconciled payments of cost-sharing reductions | ||||||||||||||||||||||||||||||||||||
1.5 Federal Transitional Reinsurance Program payments from HHS | ||||||||||||||||||||||||||||||||||||
1.6 Federal Risk Adjustment Program net payments expected from HHS / (charges payable to HHS) (as indicated by HHS as of 6/30) | ||||||||||||||||||||||||||||||||||||
1.7 Reserved | ||||||||||||||||||||||||||||||||||||
1.8 Shared Savings payments to enrollees | ||||||||||||||||||||||||||||||||||||
1.9 MLR numerator | ||||||||||||||||||||||||||||||||||||
2. Medical Loss Ratio Denominator | ||||||||||||||||||||||||||||||||||||
2.1 Premium earned including Federal and State high risk programs and adjusted for net premium stabilization program payments / (charges) | ||||||||||||||||||||||||||||||||||||
2.2 Federal and State taxes and licensing or regulatory fees | ||||||||||||||||||||||||||||||||||||
2.3 MLR Denominator (Lines 2.1 - 2.2) | ||||||||||||||||||||||||||||||||||||
3. Credibility Adjustment | ||||||||||||||||||||||||||||||||||||
3.1 Life-years | ||||||||||||||||||||||||||||||||||||
3.2 Base credibility factor | ||||||||||||||||||||||||||||||||||||
3.3 Average deductible | ||||||||||||||||||||||||||||||||||||
3.4 Deductible factor | ||||||||||||||||||||||||||||||||||||
3.5 Credibility adjustment (Lines 3.2 x 3.4 (do not round)) | ||||||||||||||||||||||||||||||||||||
4. MLR Calculation (for issuers with at least 1,000 life years in the Total column of Line 3.1) | ||||||||||||||||||||||||||||||||||||
4.1 Preliminary MLR (Lines 1.9 / 2.3) | ||||||||||||||||||||||||||||||||||||
4.2 Credibility adjustment (Line 3.5, if applicable) | ||||||||||||||||||||||||||||||||||||
4.3 Credibility-adjusted MLR (Lines 4.1 + 4.2) | ||||||||||||||||||||||||||||||||||||
5. Rebate Calculation | ||||||||||||||||||||||||||||||||||||
5.1 MLR standard | ||||||||||||||||||||||||||||||||||||
5.2 Credibility-adjusted MLR (Line 4.3) | ||||||||||||||||||||||||||||||||||||
5.3 Adjusted earned premium (Lines 2.1 - 2.2 CY) | ||||||||||||||||||||||||||||||||||||
5.4 Rebate amount if credibility-adjusted MLR is less than MLR standard (Lines (5.1 - 5.2) x 5.3) | ||||||||||||||||||||||||||||||||||||
5.5 Optional: single-year rebate liability (Line 2.3 x [Line 5.1 - (Lines 4.1 + 4.2)]) | ||||||||||||||||||||||||||||||||||||
5.6 Optional: paid rebate liability (see instructions) | ||||||||||||||||||||||||||||||||||||
5.7 Optional: unpaid rebate liability (Lines 5.5 - 5.6) | ||||||||||||||||||||||||||||||||||||
5.8 Limited payable rebate amount (see instructions) | ||||||||||||||||||||||||||||||||||||
6. Temporary Adjustments | ||||||||||||||||||||||||||||||||||||
6.1 Reserved for future use | ||||||||||||||||||||||||||||||||||||
6.1a Reserved for future use | ||||||||||||||||||||||||||||||||||||
6.1b Reserved for future use | ||||||||||||||||||||||||||||||||||||
6.2 Reserved for future use | ||||||||||||||||||||||||||||||||||||
6.2a Reserved for future use | ||||||||||||||||||||||||||||||||||||
6.2b Reserved for future use | ||||||||||||||||||||||||||||||||||||
6.2c Reserved for future use | ||||||||||||||||||||||||||||||||||||
6.2d Reserved for future use | ||||||||||||||||||||||||||||||||||||
6.2e Reserved for future use | ||||||||||||||||||||||||||||||||||||
6.2f Reserved for future use |
Part 4 Rebate Disbursement | |||||||||
Line Description | 1 Health Insurance Coverage INDIVIDUAL |
2 Health Insurance Coverage SMALL GROUP |
3 Health Insurance Coverage LARGE GROUP |
4 Mini-Med Plans INDIVIDUAL |
5 Mini-Med Plans SMALL GROUP |
6 Mini-Med Plans LARGE GROUP |
7 Expatriate Plans SMALL GROUP |
8 Expatriate Plans LARGE GROUP |
9 Student Health Plans INDIVIDUAL |
1. Number of policies / certificates (from Part 1, Line 7.1) | |||||||||
2. Number of policyholders/subscribers owed rebates | |||||||||
2.a Number of group policyholders being paid a rebate | |||||||||
2.b Number of subscribers being paid a rebate | |||||||||
2.c Number of group policyholders whose rebate is de minimis | |||||||||
2.d Number of subscribers whose rebate is de minimis | |||||||||
3. Total amount of rebates | |||||||||
3.a Total amount of rebates (from Part 3, Line 5.4 or 5.8) | |||||||||
3.b Amount of de minimis rebates | |||||||||
3.c Amount of rebates being paid by premium credit | |||||||||
3.d Amount of rebates being paid by lump-sum reimbursement | |||||||||
3.e Amount of rebates prepaid in advance of filing the MLR Form | |||||||||
4. Prior MLR year rebates | |||||||||
4.a Total amount of rebates paid for the previous MLR reporting year | |||||||||
4.b Total amount of rebates still owed for the previous MLR reporting year | |||||||||
4.c Percentage of notices sent timely to individual policy subscribers or group policyholders owed a rebate | |||||||||
4.d Percentage of notices sent timely to subscribers of group policies owed a rebate | |||||||||
4.e Percentage of rebates paid timely to individual policy subscribers or group policyholders owed a rebate | |||||||||
4.f Percentage of rebates paid timely to subscribers of group policies owed a rebate | |||||||||
4.g Amount of unclaimed rebates from prior MLR reporting years | |||||||||
4.h Describe methods used to locate policyholders/subscribers for prior MLR reporting year's unclaimed rebates: | |||||||||
4.i Describe disbursement of prior MLR reporting year's unclaimed rebates: |
Part 5 Additional Responses | ||
Line Description | Tax Rate | |
1. If an amount is reported in Part 1 Line 3.2c, Community benefit expenditures, provide the state premium tax rate used to determine the reported amount: | ||
2. If the issuer reported amounts in Part 2 Line 2.15 Blended rate adjustment provide the affiliate(s) name(s) with whom blended rate adjustments were made. | ||
Name of Affiliate | ||
3. If the issuer reported amounts in the Dual Contract 3/31 Columns provide the affiliate(s) name(s) with whom experience is being reported. | ||
Name of Affiliate | ||
4. If the issuer entered into any 100% assumptive reinsurance agreements with a novation during the MLR reporting year, provide the name(s) of the entity(ies) with whom the agreement was (were) made and the effective date of the novation. | ||
Name of Entity with whom Agreement was made | Effective Date of Novation | |
5. If the issuer sold any business in the MLR reporting year, and the novation was effective during the MLR reporting year, provide the name(s) of the entity(ies) to which the business was sold and the date of the sale or transfer. | ||
Name of Entity to whom business was sold or transferred | Effective Date of sale or transfer | |
6. If the issuer has any 100% indemnity reinsurance and administrative agreements effective prior to March 23, 2010, for which the assuming entity is responsible for 100% of the ceding entity's financial risk and takes on all of the administration of the block, report the name(s) of the entity(ies) that is (are) reporting the experience related to such business. | ||
Part 6 Expense Allocation | |||
1. Incurred Claims | |||
Incurred Claims 1 Description of Expense Element (by Type) |
Incurred Claims 2 NEW |
Incurred Claims 3 Detailed Description of Expense Allocation Methods |
|
2.a Federal taxes and assessments | |||
Federal taxes and assessments 1 Description of Expense Element (by Type) |
Federal taxes and assessments 2 NEW |
Federal taxes and assessments 3 Detailed Description of Expense Allocation Methods |
|
2.b State insurance, premium and other taxes | |||
State insurance, premium and other taxes 1 Description of Expense Element (by Type) |
State insurance, premium and other taxes 2 NEW |
State insurance, premium and other taxes 3 Detailed Description of Expense Allocation Methods |
|
2.c Community benefit expenditures | |||
Community benefit expenditures 1 Description of Expense Element (by Type) |
Community benefit expenditures 2 NEW |
Community benefit expenditures 3 Detailed Description of Expense Allocation Methods |
|
2.d Regulatory authority licenses and fees | |||
Regulatory authority licenses and fees 1 Description of Expense Element (by Type) |
Regulatory authority licenses and fees 2 NEW |
Regulatory authority licenses and fees 3 Detailed Description of Expense Allocation Methods |
|
3.a Improve health outcomes | |||
Improve health outcomes 1 Description of Expense Element (by Type) |
Improve health outcomes 2 NEW |
Improve health outcomes 3 Detailed Description of Expense Allocation Methods |
|
3.b Activities to prevent hospital readmission | |||
Activities to prevent hospital readmission 1 Description of Expense Element (by Type) |
Activities to prevent hospital readmission 2 NEW |
Activities to prevent hospital readmission 3 Detailed Description of Expense Allocation Methods |
|
3.c Improve patient safety and reduce medical errors | |||
Improve patient safety and reduce medical errors 1 Description of Expense Element (by Type) |
Improve patient safety and reduce medical errors 2 NEW |
Improve patient safety and reduce medical errors 3 Detailed Description of Expense Allocation Methods |
|
3.d Wellness and health promotion activities | |||
Wellness and health promotion activities 1 Description of Expense Element (by Type) |
Wellness and health promotion activities 2 NEW |
Wellness and health promotion activities 3 Detailed Description of Expense Allocation Methods |
|
3.e Health Information Technology expenses related to healthcare quality | |||
Health Information Technology expenses related to healthcare quality 1 Description of Expense Element (by Type) |
Health Information Technology expenses related to healthcare quality 2 NEW |
Health Information Technology expenses related to healthcare quality 3 Detailed Description of Expense Allocation Methods |
|
4.a Cost containment expenses not included in quality improvement expenses | |||
Cost containment expenses not included in quality improvement expenses 1 Description of Expense Element (by Type) |
Cost containment expenses not included in quality improvement expenses 2 NEW |
Cost containment expenses not included in quality improvement expenses 3 Detailed Description of Expense Allocation Methods |
|
4.b All other claims adjustment expenses | |||
All other claims adjustment expenses 1 Description of Expense Element (by Type) |
All other claims adjustment expenses 2 NEW |
All other claims adjustment expenses 3 Detailed Description of Expense Allocation Methods |
|
4.c Direct sales salaries and benefits | |||
Direct sales salaries and benefits 1 Description of Expense Element (by Type) |
Direct sales salaries and benefits 2 NEW |
Direct sales salaries and benefits 3 Detailed Description of Expense Allocation Methods |
|
4.d Agents and brokers fees and commissions | |||
Agents and brokers fees and commissions 1 Description of Expense Element (by Type) |
Agents and brokers fees and commissions 2 NEW |
Agents and brokers fees and commissions 3 Detailed Description of Expense Allocation Methods |
|
4.e Other taxes | |||
Other taxes 1 Description of Expense Element (by Type) |
Other taxes 2 NEW |
Other taxes 3 Detailed Description of Expense Allocation Methods |
|
4.f Other general and administrative expenses | |||
Other general and administrative expenses 1 Description of Expense Element (by Type) |
Other general and administrative expenses 2 NEW |
Other general and administrative expenses 3 Detailed Description of Expense Allocation Methods |
|
4.g Community benefit expenditures | |||
Community benefit expenditures 1 Description of Expense Element (by Type) |
Community benefit expenditures 2 NEW |
Community benefit expenditures 3 Detailed Description of Expense Allocation Methods |
|
Attestation Statement |
The officers of this reporting issuer being duly sworn, each attest that he/she is the described officer of the reporting issuer, and that this MLR Reporting Form, the Company/Issuer Associations, and any supplemental submission that the issuer includes are full and true statements of all the elements included therein for the MLR reporting year, and that the MLR Reporting Form has been completed in accordance with the Department of Health and Human Services’ reporting instructions, according to the best of his/her information, knowledge and belief. Furthermore, the scope of this attestation by the described officer includes any related electronic filings and postings for the MLR reporting year and which are required by Department of Health and Human Services under section 2718 of the Public Health Service Act and implementing regulation. |
____________________________ |
Chief Executive Officer/President |
____________________________ |
Chief Financial Officer |
Table 1 - Base Credibility Adjustment Factors | Table 3 - State and Territory Names | Table 4 - Reporting Years | Table 5 - Yes/No | ||||
Life Years | Base credibility factor | Alaska | 2011 | Yes | |||
- | 0.0% | Alabama | 2012 | No | |||
1,000 | 8.3% | Arkansas | 2013 | ||||
2,500 | 5.2% | American Samoa | 2014 | ||||
5,000 | 3.7% | Arizona | 2015 | ||||
10,000 | 2.6% | California | 2016 | ||||
25,000 | 1.6% | Canada | 2017 | ||||
50,000 | 1.2% | Colorado | 2018 | ||||
75,000 | 0.0% | Connecticut | 2019 | ||||
District of Columbia | 2020 | ||||||
Delaware | 2021 | ||||||
Florida | 2022 | ||||||
Table 2 - Deductible Factors | Georgia | 2023 | |||||
Average Health Plan Deductible | Deductible factor | Guam | 2024 | ||||
$0 | 1.000 | Hawaii | 2025 | ||||
$2,500 | 1.164 | Iowa | 2026 | ||||
$5,000 | 1.402 | Idaho | 2027 | ||||
$10,000 | 1.736 | Illinois | 2028 | ||||
Indiana | 2029 | ||||||
Kansas | 2030 | ||||||
Kentucky | 2031 | ||||||
Louisiana | 2032 | ||||||
Massachusetts | 2033 | ||||||
Maryland | 2034 | ||||||
Maine | 2035 | ||||||
Michigan | 2036 | ||||||
Minnesota | 2037 | ||||||
Missouri | 2038 | ||||||
MP | 2039 | ||||||
Mississippi | 2040 | ||||||
Montana | 2041 | ||||||
North Carolina | 2042 | ||||||
North Dakota | 2043 | ||||||
Nebraska | 2044 | ||||||
New Hampshire | 2045 | ||||||
New Jersey | 2046 | ||||||
New Mexico | 2047 | ||||||
Nevada | 2048 | ||||||
New York | 2049 | ||||||
Ohio | 2050 | ||||||
Oklahoma | 2051 | ||||||
Oregon | 2052 | ||||||
Other Territories | 2053 | ||||||
Pennsylvania | 2054 | ||||||
Puerto Rico | 2055 | ||||||
Rhode Island | 2056 | ||||||
South Carolina | 2057 | ||||||
South Dakota | 2058 | ||||||
Tennessee | 2059 | ||||||
Texas | 2060 | ||||||
Utah | |||||||
Virginia | |||||||
Virgin Islands | |||||||
Vermont | |||||||
Washington | |||||||
Wisconsin | |||||||
West Virginia | |||||||
Wyoming | |||||||
Grand Total |
File Type | application/vnd.openxmlformats-officedocument.spreadsheetml.sheet |
File Modified | 0000-00-00 |
File Created | 0000-00-00 |